Enoblituzumab, previously known as TJ-271 or MGA271, represents a novel antibody directed at CD33, a antigen found predominantly on cancer tissues. The antibody functions as an two-pronged molecule, simultaneously https://jaygdqf546443.mpeblog.com/74110294/enoblituzumab-a-deep-dive-into-tj-271-and-mga271